Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

CareView Communications (CRVW) Research & Development (2016 - 2025)

CareView Communications' Research & Development history spans 16 years, with the latest figure at $610112.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 32.61% year-over-year to $610112.0; the TTM value through Sep 2025 reached $1.7 million, down 49.31%, while the annual FY2024 figure was $2.4 million, 14.35% down from the prior year.
  • Research & Development for Q3 2025 was $610112.0 at CareView Communications, up from $547061.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.1 million in Q4 2023 and bottomed at -$37299.0 in Q4 2024.
  • The 5-year median for Research & Development is $537779.0 (2023), against an average of $529722.2.
  • The largest annual shift saw Research & Development surged 265.26% in 2023 before it crashed 103.42% in 2024.
  • A 5-year view of Research & Development shows it stood at $97964.0 in 2021, then skyrocketed by 204.73% to $298521.0 in 2022, then soared by 265.26% to $1.1 million in 2023, then crashed by 103.42% to -$37299.0 in 2024, then surged by 1735.73% to $610112.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVW's Research & Development are $610112.0 (Q3 2025), $547061.0 (Q2 2025), and $580385.0 (Q1 2025).